Repealed, 2002

KRS § 304.17A-137, under INSURANCE CODE.

KRS § 304.17A-137

Catchline at repeal: Coverage for prescribed cancer drugs not approved by the Federal Food and Drug Administration for cancer treatment -- Review panel for off-label uses.